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Introduction
Glycosaminoglycans (GAGs) are linear polysaccharides found ubiquitously on animal cell surfaces and in the extracellular matrix. GAGs usually occur linked to protein cores as proteoglycans, and in most cases accomplish their biological functions through interactions with ligand proteins [1] [2] [3] [4] . Such interactions have a strong electrostatic component mediated by the negatively charged functional groups of GAGs (sulfates, sulfonamides, and carboxyl groups) and positively charged amino-acid side-chains of proteins (lysines, arginines and occasionally histidines). In enzymes which are involved in GAG biosynthesis and degradation, GAGs bind in deep canyons and clefts 5 . In complexes with growth factors, however, GAGs often sit in shallow grooves on protein surfaces [6] [7] [8] , making these interactions less specific than protein-protein interactions. Charge density, rather than a requirement for a specific structural motif, is often sufficient for complex formation [9] [10] [11] . A well documented exception is the interaction of a heparin pentasaccharide with antithrombin III which requires a very specific GAG motif 12, 13 .
Nonetheless, GAG composition varies depending on the type and developmental stage of the tissue in which they are expressed [14] [15] [16] , hinting at the functional relevance of subtle structural variations.
Indeed, changes in GAG structure and composition have been identified as possible biomarkers for cancer 17, 18 . Developing new methods for the characterization of protein-GAG complexes 19 is therefore important for our understanding of the biological roles of GAGs and essential for realizing their therapeutic potential 10 .
The growing awareness of the role played by heparan sulfate (HS) in cell-cell communication and the potential applications of cross-linked heparin-protein conjugates for medical purposes underline the importance of structural elucidation of such constructs. HS/heparin chains cross-linked to protein are likely to be more stable to enzymatic degradation than the free GAGs. Covalent protein-GAG conjugates may also be more potent in the formation of ternary complexes, such as with signaling receptors, than transient, non-covalent protein-GAG complexes 20 . Recently, a synthetic CD4-HS glycoconjugate was shown to inhibit CCR5-and CXCR4-mediated HIV-1 attachment and viral entry 21 .
In this study we present novel approaches for the characterization of non-covalent protein-GAG complexes and covalently cross-linked protein-GAG conjugates, in solution, by a combination of NMR spectroscopy and mass spectrometry. Our methodology is illustrated using the interaction between HS and module 7 of human complement factor H (CFH~7). Mature HS contains variably sulfated domains interrupted by domains essentially lacking sulfation 22 and, typically, proteins bind to the highly sulfated domains 23 . Consequently, heparin, which shares an identical carbohydrate skeleton with HS but displays a higher and more evenly distributed level of sulfation, is often used in structural studies as a HS mimetic, as is the case in the present study.
CFH, the main fluid-phase regulator of the alternative pathway of complement 24 , is a 155-kDa heparin-binding protein consisting of twenty ~7-kDa complement control protein modules (CCPs).
CCPs have a prolate ellipsoid shape, high β-sheet content and two conserved disulfide bonds per module. They are connected by linkers of 3-8 residues, giving CFH the appearance of 20 beads on a string. By binding to HS or other cell surface polyanions 25 , CFH protects host cells from complement attack 26, 27 . This interaction is thought to lie at the centre of host-cell protection from the innate immune system, and is particularly important for cells lacking alternative membrane-bound regulators.
The Y402H single nucleotide polymorphism in CFH~7, present in about 30% of the population, is associated (in homozygous individuals) with a 7-fold increase in the occurrence of age-related macular degeneration (AMD) [28] [29] [30] [31] . As CFH~7 contributes directly to one of the two principal heparinbinding sites in CFH, it was proposed that a change in polyanion-binding properties of the histidine allotype compromises the ability of CFH to protect the Bruch's membrane from complement-mediated damage. This membrane underlies the retinal pigment epithelium, and its damage triggers inflammatory processes eventually leading to AMD onset 32 . In this study we have used the Y402 variant, which is referred to from now on as CFH~7. . This methodology couples the amino group of a lysine side-chain to the activated carboxylate of a GAG oligosaccharide [36] [37] [38] [39] . Assuming that the binding mode of the activated carbohydrate is similar to that of the unmodified oligosaccharide, formation of an amide bond provides evidence for spatial proximity between a specific lysine sidechain and a carboxyl group of the oligosaccharide.
Experimental Section

Preparation of fully sulfated heparin tetrasaccharide
Fully sulfated tetrasaccharide, UA(2S)-GlcNS(6S)-IdoA(2S)-GlcNS(6S), was produced by controlled, partial, heparinase I digestion of low-molecular weight heparin, and subsequent purification by gel-filtration and ion-exchange chromatography as described previously 33 . The purity was checked by 1 H-NMR and concentrations were determined using absorbance at 232 nm with a molar absorption coefficient of 5200 M -1 cm -1 40 .
Preparation of CFH~7
A protein construct containing CFH residues 386 to 446 (Y402) was cloned into the Pichia pastoris expression vector pPICZαB (Invitrogen) and transformed into the P. pastoris strain KM71H , was also used in this study.
Protein concentrations were determined using absorbance at 280 nm (calculated extinction coefficient
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NMR experiments
All NMR experiments, with the exception of were fitted to an exponential decay in Gnuplot.
Trypsin digestion
Samples of 65 μg CFH~7, either free or as cross-linked conjugate, were treated with 0.25 mM dithiothreiol (DTT) and 8 M urea in a total volume of 400 μL and incubated at 75 °C for 1 hr. The unfolded and reduced samples were alkylated by incubation with 125 mM iodoacetamide at room temperature (total volume 500 μL). Dialysis into 50 mM ammonium acetate, pH 7.4, was conducted overnight before 2.5 µg trypsin (sequencing grade, Promega) was added in a volume of 500 μL.
Digestion proceeded at 37 °C for 1.5 hrs and trypsin was then reversibly deactivated by reducing the pH to 4.0 with 1 M acetic acid and cooling the samples to 4 °C. MALDI-TOF MS was used to assess the degree of digestion. For complete digestion, trypsin was re-activated by raising the sample pH to 8.2 and incubating overnight at 37 °C.
Microwave-assisted acid hydrolysis
Cross-linked conjugate (30 μL of 80 μM) was mixed with 0.1 mM DTT and 20% trifluoroacetic acid (TFA) in a total volume of 50 μL in a 1.5-mL Eppendorf microcentrifuge tube 47 . The sample was placed within a glass beaker in a domestic microwave oven, along with a second glass beaker containing roughly 100 mL water for absorption of excess radiation, and heated with 950 Watts for 6 mins in two-minute steps. After each step, the sample was opened to release the pressure. The sample was then subjected to MALDI-TOF MS. The web server ProSight PTM (https://prosightptm.scs.uiuc.edu/) was used to assist in peptide identification.
Mass spectrometry
MALDI-TOF spectra were acquired on a Voyager-DE STR MALDI-TOF instrument (Applied Biosystems) with a nitrogen laser in positive mode. Matrices used were sinapinic acid for protein samples and alpha-cyano-4-hydroxy-cinnamic acid (CHCA) for peptides. Matrices were prepared by mixing 15 mg sinapinic acid or 10 mg CHCA with 400 μL double-distilled water, 100 μL 3% TFA and 500 μL acetonitrile, followed by sonication for 3 mins. Generally, 0.5 μL of protein or peptide samples were mixed with 0.5 μL of the appropriate matrix directly on the MALDI-TOF plate. The laser intensity was adjusted manually for each sample. Accurate mass spectra were recorded using a 12 T Apex-Qe FT-ICR mass spectrometer (Bruker Daltonics, Billerica, MA). Sample infusion was performed in positive-ion mode, using a TriVersa NanoMate (Advion Biosciences, Ithica, NY) chipbased nanoelectrospray ionisation (nanoESI) robot. The broadband spectrum was acquired from 100 accumulations using a time domain data size of 512k word, prior to Fourier transformation. The mass error between the most abundant isotope peak measured at 1693.09 m/z and the peak in the simulated pattern was 8 ppm. The mass of the cross-linked CFH~7 : tetrasaccharide conjugate was calculated as the individual masses of the free protein plus tetrasaccharide minus the one water molecule eliminated during cross-linking; all sulfates and the remaining carboxyl group in the GAG moiety were considered to be protonated. close proximity to Y402, the residue whose variation is linked to AMD. CFH~7 contains five lysines and four arginines which are also highlighted. Five of these basic residues are located towards the Nterminus, two occur within the middle of the module, while the two remaining ones are located close to the C-terminus. Only three (R404, K405 and K446) out of these nine residues had backbone NH 15 N and 1 H resonances significantly affected by binding of the tetrasaccharide (Fig 1) . 
Results
Titration
Dimerisation of CFH~7 caused by heparin tetrasaccharide
As a consequence of the helical nature of heparin [48] [49] [50] , its negative charges are distributed on both faces of the helix and can be presented to proteins on either side. Indeed a 1:2 GAG:protein complex has been observed for GAG fragments as short as tetrasaccharides, e.g. in the crystal structure of acidic fibroblast growth factor in complex with a fully sulfated heparin tetrasaccharide 6 . In solution, dimerisation would be expected to slow down molecular tumbling and affect + resonances were subsequently assigned through a comparison of the lysine side-chain carbon frequencies in 3D (H)CCENH 3 41 and (H)C(CO)NH-TOCSY 43 spectra (Fig. 1S) Only two lysine residues (K405 and K388) exhibited significant chemical shift changes after addition of tetrasaccharide (Fig 3a) . 
Zero-length cross-linking of protein-GAG complexes
The heparin tetrasaccharide was cross-linked to CFH~7 as described in the Experimental section. The products were separated by cation-exchange chromatography at pH 6.0 (Fig. 4) , and fractions were analyzed by positive mode MALDI-TOF MS. Unlike the free protein that binds and is eluted with 0.3M NaCl (7320.5 Da peak in Fig. 4) , the cross-linked CFH~7: heparin tetrasaccharide conjugate, being more anionic, did not bind and was recovered in the flow through. It yielded the strongest peak respectively). These fragments included lysine residues K388 and K424, indicating that these had not been modified by cross-linking. Additionally, the generation of the first of these peptides (S 411 -K 424 )
suggests that K410 is also unmodified, as this residue is still recognized, and cleaved at by trypsin.
Chemical fragmentation using TFA and microwave radiation 47 undertaken as a complementary approach yielded fragments which differed from those obtained using trypsin. The chemical cleavage effectively 'sequenced' the C-terminus of the protein (Fig. 4S) , and established that K446 is also unmodified. In summary, the MS techniques directly showed that residues K388, K424 and K446 are not modified by cross-linking, and implied that K410 also remains unmodified. Thus, according to these experiments, K405 is the point of attachment of tetrasaccharide to CFH~7 within the conjugate.
Discussion
Previous studies based on standard 1 H, 15 N-HSQC spectra identified two GAG-binding sites in CFH~7 located near the C-and N-termini 33, 34 . These sites may now be analyzed separately in the light of the experimental results presented above. Four basic residues could potentially contribute to the binding at the C-terminus: K424, R441, R444 and K446. Of these only R444 showed a significant movement of side-chain resonances in the titration experiments monitored by H 2 CN spectra (Fig 3b) .
At the same time backbone NH resonances of R444 remained relatively unperturbed. Inverse observations were made for K446, where backbone NH resonances were perturbed significantly upon titration while the side-chain resonances did not move at all (Fig 3a) . did not show perturbation of the backbone NH cross peaks, while the other two residues did. The 1 H, 15 N-HSQC and HISQC spectra of the cross-linked conjugate lacked cross peaks from residues in the N-terminal portion of the protein, which could be explained by an intermediate-timescale
conformational exchange induced by the attachment of the tetrasaccharide (Fig. 2, Fig. 2S ). MS analysis of the trypsin digest of the conjugate established that K388 and K410 were not modified, leaving only one lysine residue, K405, available for the tetrasaccharide attachment. Combined MS and NMR data therefore allow us to locate the site of tetrasaccharide cross-linking to the side chain of K405.
Overall, we conclude that the side-chains of K405, R404, and K388 provide most of the chargecharge interactions of the N-terminal HS/heparin-binding site of CFH~7. This is in agreement with mutagenesis studies which showed that the mutations K405A and R404A significantly reduced heparin binding to CFH~6-8 57 . The K388A mutation caused a smaller decrease in heparin affinity 57 , but in the context of a R387A/K388A double mutationour solution data with the X-ray structure of the CFH~6-8(H402)-SOS complex 34 The X-ray structure shows hydrogen bonds between the sulfate and backbone NH of F391 in the immediate vicinity of Y402. This is consistent with the movement of NH backbone resonances Y390
and F391 observed in our titrations of CFH~7 with the tetrasaccharide (Fig 1a) .
Our data position the tetrasaccharide near the three basic residues K405, R404, and K388, and thus provide strong experimental evidence for its binding in close proximity to Y402. This is in agreement with previous docking studies of a highly sulfated heparin pentasaccharide 57 . It was suggested previously that the mode of binding of SOS in the CFH~6-8 (H402)-SOS complex 34 is incompatible with the position of the Y402 side chain found in the solution structure of CFH~7 (Y402) 33 . It is therefore likely that different sulfated molecules interact differently with the N-terminal binding site of CFH~7. Differences were also observed in binding to Y402 and H402 of heparin species with various levels and patterns of sulfation 57 . More atomic resolution data will be needed to explain these observations. Given the difficulties in crystallizing factor H modules in the presence of GAGs, NMR will play an important role in these investigations, which will benefit from the methodology outlined in this work.
Summarizing our findings from the methodological point of view, we have shown that the H 2 CN experiment 34 , although requiring a double-labeled sample, is a very useful tool for monitoring lysine and arginine side-chain resonances of protein-GAG complexes under physiological conditions. The usefulness of the HISQC experiment is limited due to the fact that it requires non-physiological conditions. It can, however, provided useful information about covalently-linked, protein-GAG glycoconjugates.
Peptide analysis after trypsin digestion and chemical cleavage was employed to locate the crosslinking site. Four lysine residues out of five were shown, unambiguously, to be unmodified within a conjugate consisting of a tetrasaccharide moiety chemically cross-linked to a lysine side chain. It must, therefore, be the case that K405 is the site at which the tetrasaccharide is attached. No peptide containing the K405 -tetrasaccharide conjugate could be detected by MALDI-TOF, presumably due to the large overall negative charge predicted for such a species. If identification of a GAG-peptide construct were needed, negative-ion ES-MS spectrometry would be an option 21 . Another potential hurdle to positive identification of the conjugated proteolytic fragment, however, is that covalently attached oligosaccharides might compromise access by trypsin or Lys-C not just to the cleavage site directly following the conjugated lysine residue but also to nearby cleavage sites. This is likely to be a particular problem with GAG-binding proteins since they often contain clusters of lysine and arginine residues.
In a related zero-length cross-linking approach reported previously 38 a GAG-binding protein was cross-linked to heparin immobilised on beads. The glycoconjugate was then subjected to proteolytic digestion on the beads, with subsequent identification of the cross-linked peptides by N-terminal sequencing, which gives a "gap" at the position of the cross-linked amino acid residue. This solid phase assay requires immobilised GAGs, and only inhomogeneous heparin preparations are presently commercially available in this form. The authors of this approach also observed some cross-linking to arginines. This was not the case in our study as all arginine residues were recognized by trypsin, and fragments containing unmodified arginines were also present in the chemically-cleaved material. Our approach, being solution-based, can be equally applied to protein cross-linking to any type, size, and specific sequence of GAG oligosaccharides. Furthermore, whereas N-terminal protein sequencing is becoming increasingly less available, cross-linking in solution is more amenable to MS techniques, the application of which is rapidly evolving for GAGs 59, 60, 61 .
Conclusions
We have pointed out the shortcomings of the exclusive use of 
